Use of cidofovir in pediatric patients with adenovirus infection

F1000Research

Volumn 5, Issue , 2016, Pages

  Levy, Ofer ^a,b   Ganapathi, Lakshmi ^a,b   Arnold, Alana ^a   Jones, Sarah ^a   Patterson, Al ^a   Graham, Dionne ^a   Harper, Marvin ^a,b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Adenovirus; Anti viral; Cidofovir; Immunocompromised; Pediatric; Solid organ; Stem cell

Indexed keywords

EID: 85010850404     PISSN: 20461402     EISSN: 1759796X     Source Type: Journal    
DOI: 10.12688/f1000research.8374.2     Document Type: Article

References (33)

1. Ison MG: Adenovirus infections in transplant recipients. Clin Infect Dis. 2006;43(3):331-339. 16804849 10.1086/505498
2. Carrigan DR: Adenovirus infections in immunocompromised patients. Am J Med. 1997;102(3A):71-74. 10868146
3. Howard DS Phillips II GL Reece DE: Adenovirus infections in hematopoietic stem cell transplant recipients. Clin Infect Dis. 1999;29(6):1494-1501. 10585802 10.1086/313514
4. Hale GA Heslop HE Krance RA: Adenovirus infection after pediatric bone marrow transplantation. Bone Marrow Transplant. 1999;23(3):277-282. 10084260 10.1038/sj.bmt.1701563
5. Hierholzer JC: Adenoviruses in the immunocompromised host. Clin Microbiol Rev. 1992;5(3):262-274. 1323383 358244 10.1128/CMR.5.3.262
6. Gavin PJ Katz BZ: Intravenous ribavirin treatment for severe adenovirus disease in immunocompromised children. Pediatrics. 2002;110(1 Pt 1):e9. 12093990
7. McCarthy AJ Bergin M De Silva LM: Intravenous ribavirin therapy for disseminated adenovirus infection. Pediatr Infect Dis J. 1995;14(11):1003-1004. 8584339 10.1097/00006454-199511000-00017
8. Chen FE Liang RH Lo JY: Treatment of adenovirus-associated haemorrhagic cystitis with ganciclovir. Bone Marrow Transplant. 1997;20(11):997-999. 9422482 10.1038/sj.bmt.1700997
9. Kawakami M Ueda S Maeda T: Vidarabine therapy for virus-associated cystitis after allogeneic bone marrow transplantation. Bone Marrow Transplant. 1997;20(6):485-490. 9313882 10.1038/sj.bmt.1700923
10. Kitabayashi A Hirokawa M Kuroki J: Successful vidarabine therapy for adenovirus type 11-associated acute hemorrhagic cystitis after allogeneic bone marrow transplantation. Bone Marrow Transplant. 1994;14(5):853-854. 7889020
11. Saquib R Melton LB Chandrakantan A: Disseminated adenovirus infection in renal transplant recipients: the role of cidofovir and intravenous immunoglobulin. Transpl Infect Dis. 2010;12(1):77-83. 19761559 10.1111/j.1399-3062.2009.00452.x
12. Muller WJ Levin MJ Shin YK: Clinical and in vitro evaluation of cidofovir for treatment of adenovirus infection in pediatric hematopoietic stem cell transplant recipients. Clin Infect Dis. 2005;41(12):1812-1816. 16288409 10.1086/498151
13. Ljungman P Ribaud P Eyrich M: Cidofovir for adenovirus infections after allogeneic hematopoietic stem cell transplantation: a survey by the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant. 2003;31(6):481-486. 12665844 10.1038/sj.bmt.1703798
14. Hoffman JA Shah AJ Ross LA: Adenoviral infections and a prospective trial of cidofovir in pediatric hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2001;7(7):388-394. 11529489 10.1053/bbmt.2001.v7.pm11529489
15. Bhadri VA Lee-Horn L Shaw PJ: Safety and tolerability of cidofovir in high-risk pediatric patients. Transpl Infect Dis. 2009;11(4):373-379. 19392729 10.1111/j.1399-3062.2009.00391.x
16. Engelmann G Heim A Greil J: Adenovirus infection and treatment with cidofovir in children after liver transplantation. Pediatr Transplant. 2009;13(4):421-428. 18783361 10.1111/j.1399-3046.2008.01014.x
17. Yusuf U Hale GA Carr J: Cidofovir for the treatment of adenoviral infection in pediatric hematopoietic stem cell transplant patients. Transplantation. 2006;81(10):1398-1404. 16732176 10.1097/01.tp.0000209195.95115.8e
18. Legrand F Berrebi D Houhou N: Early diagnosis of adenovirus infection and treatment with cidofovir after bone marrow transplantation in children. Bone Marrow Transplant. 2001;27(6):621-626. 11319592 10.1038/sj.bmt.1702820
19. Anderson EJ Guzman-Cottrill JA Kletzel M: High-risk adenovirus-infected pediatric allogeneic hematopoietic progenitor cell transplant recipients and preemptive cidofovir therapy. Pediatr Transplant. 2008;12(2):219-227. 18307672 10.1111/j.1399-3046.2007.00851.x
20. Wallot MA Dohna-Schwake C Auth M: Disseminated adenovirus infection with respiratory failure in pediatric liver transplant recipients: impact of intravenous cidofovir and inhaled nitric oxide. Pediatr Transplant. 2006;10(1):121-127. 16499602 10.1111/j.1399-3046.2005.00411.x
21. Ribaud P Scieux C Freymuth F: Successful treatment of adenovirus disease with intravenous cidofovir in an unrelated stem-cell transplant recipient. Clin Infect Dis. 1999;28(3):690-691. 10194105 10.1086/517222
22. Naesens L Lenaerts L Andrei G: Antiadenovirus activities of several classes of nucleoside and nucleotide analogues. Antimicrob Agents Chemother. 2005;49(3):1010-1016. 15728896 10.1128/AAC.49.3.1010-1016.2005 549266
23. Morfin F Dupuis-Girod S Mundweiler S: In vitro susceptibility of adenovirus to antiviral drugs is species-dependent. Antivir Ther. 2005;10(2):225-229. 15865216
24. Carter BA Karpen SJ Quiros-Tejeira RE: Intravenous Cidofovir therapy for disseminated adenovirus in a pediatric liver transplant recipient. Transplantation. 2002;74(7):1050-1052. 12394854
25. Doan ML Mallory GB Kaplan SL: Treatment of adenovirus pneumonia with cidofovir in pediatric lung transplant recipients. J Heart Lung Transplant. 2007;26(9):883-889. 17845926 10.1016/j.healun.2007.06.009
26. Sivaprakasam P Carr TF Coussons M: Improved outcome from invasive adenovirus infection in pediatric patients after hemopoietic stem cell transplantation using intensive clinical surveillance and early intervention. J Pediatr Hematol Oncol. 2007;29(2):81-85. 17279003 10.1097/MPH.0b013e318030875e
27. Williams KM Agwu AL Dabb AA: A clinical algorithm identifies high risk pediatric oncology and bone marrow transplant patients likely to benefit from treatment of adenoviral infection. J Pediatr Hematol Oncol. 2009;31(11):825-831. 19801951 10.1097/MPH.0b013e3181b7873e 4251427
28. Humar A Kumar D Mazzulli T: A surveillance study of adenovirus infection in adult solid organ transplant recipients. Am J Transplant. 2005;5(10):2555-9. 16162207 10.1111/j.1600-6143.2005.01033.x
29. Seidemann K Heim A Pfister ED: Monitoring of adenovirus infection in pediatric transplant recipients by quantitative PCR: report of six cases and review of the literature. Am J Transplant. 2004;4(12):2102-8. 15575915 10.1111/j.1600-6143.2004.00631.x
30. Leruez-Ville M Minard V Lacaille F: Real-time blood plasma polymerase chain reaction for management of disseminated adenovirus infection. Clin Infect Dis. 2004;38(1):45-52. 14679447 10.1086/380450
31. Wold WS Toth K: New drug on the horizon for treating adenovirus. Expert Opin Pharmacother. 2015;16(14):2095-9. 26330121 10.1517/14656566.2015.1083975 4866633
32. Ganapathi L Arnold A Jones S: Dataset 1 in: Use of cidofovir in pediatric patients with adenovirus infection. F1000Research. 2016. Data Source
33. Ganapathi L Arnold A Jones S: Dataset 2 in: Use of cidofovir in pediatric patients with adenovirus infection. F1000Research. 2016. Data Source